search

Mission

The GENESKIN project aims to disseminate knowledge and awareness, improve diagnosis and management and facilitate access to innovative treatment options for rare genetic skin diseases.
The main objectives of this project are:

  • to collect and disseminate across Europe medical data on specific groups of genetic skin diseases. The data is addressed to both professionals and the general public;
  • to test, validate and integrate diagnostic and research tools for these diseases;
  • to organise training courses and meetings on specific aspects of the diseases;
  • to promote pan-European communication pathways between patients’ organizations, ethics committees, physicians and scientists.

Activities

The project is focused on five groups of rare genetic skin diseases: ectodermal dysplasias, and disorders of epithelial adhesion, keratinisation, connective tissue and DNA repair.
Four major areas of activity have been identified:

  • Information: a dedicated website (GENESKIN website), through which both professional and non-professional users can access understandable, comprehensive and updated information on disease features, diagnosis and care.
  • Diagnosis of selected diseases: (i) to test and validate antibodies and other biological tests to be used for diagnosis; (ii) to standardise and test techniques for mutation analysis; (iii) to facilitate the exchange of biological samples for diagnostic and research purposes; (iv) to establish a virtual sample database.
  • Training: organization of courses and meetings for medical, healthcare and laboratory personnel on specific clinical, diagnostic and management aspects.
  • Communication: (i) to foster dialogue between professionals and patients’ associations by organizing regular interaction and combined activities for medical staff and the general  public; (ii) to promote the set-up of a European network of GENESKIN ethics experts; (iii) to raise public awareness of rare genetic skin diseases.

Participants

The project is run by a Consortium of 32 clinical and laboratory expert groups from 12 European countries.
Participants list:
1A) Dr. Giovanna Zambruno, Rome, Italy
1B) Dr. Giandomenico Russo, Rome, Italy
2A) Dr. Miria Stefanini, Pavia, Italy
2B) Dr. Michele D’Urso, Naples, Italy
3) Prof. Ivonne Ronchetti, Modena, Italy
4) Prof. Leena Bruckner-Tuderman, Freiburg, Germany
5) Prof. Heiko Traupe, Münster, Germany
6) Dr. Hans Christian Hennies, Cologne, Germany
7) Prof. Karl-Heinz Grzeschik, Marburg, Germany
8) Prof. John Alexander McGrath, London, United Kingdom
9A) Prof. Irene May Leigh, Dundee, United Kingdom
9B) Prof. David Peter Kelsell, London, United Kingdom
10) Prof. Alan Lehmann, Brighton, United Kingdom
11) Dr. Malcom B. Hodgins and Prof. Colin S. Munro, Glasgow, Scotland - United Kingdom
12) Mr. John Richard William Dart, Crowthorne, United Kingdom
13) Dr. Alan David Irvine, Dublin, Ireland
14A) Dr. Guerrino Meneguzzi, Nice, France
14B) Prof. Alain Hovnanian, Toulouse, France
14C) Prof. Alain Taieb, Bordeaux, France
15) Prof. Jean-Paul Ortonne and Prof. Jean-Philippe Lacour, Nice, France
16) Dr. Alain Sarasin, Villejuif, France
17) Prof. Christine Bodemer, Paris, France
18) Dr. Judith Fischer, Evry, France
19) Prof. Daniel Hohl, Lausanne, Switzerland
20) Prof. Anne De Paepe, Gent, Belgium
21) Prof. Jan H.J. Hoeijmakers, Rotterdam, Netherlands
22) Prof. Marcel F. Jonkman, Groningen, Netherlands
23) Dr. Antonio Bernad, Madrid, Spain
24) Prof. Robert Strohal, Feldkirch, Austria
25) Prof. Johann W. Bauer, Salzburg, Austria 
26) Prof. Sarolta Karpati, Budapest, Hungary
27) Prof. Anders Vahlquist, Uppsala, Sweden

 

 

ardiarts
about rare genetic skin diseases
about geneskin website
about geneskin project
news
online newsletter
links
forum
essential glossary